A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects

NCT02359032 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Astellas Pharma Europe B.V.